UPDATED Mar 12, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TSTLTristel | UK£4.70 | 0% | 42.4% | UK£223.1m | UK£4.82 | PE37x | E5.8% | 2.2% | ||
GENIGENinCode | UK£0.035 | -2.8% | -81.4% | UK£6.1m | n/a | PS3.6x | E25.7% | n/a | ||
IDHCIntegrated Diagnostics Holdings | US$0.40 | 2.3% | -12.5% | US$238.8m | n/a | PE21.4x | E27.8% | n/a | ||
INHCInduction Healthcare Group | UK£0.16 | 0% | -25.6% | UK£14.8m | n/a | PS1.3x | n/a | n/a | ||
EMISEMIS Group | UK£19.20 | 0.1% | 2.8% | UK£1.2b | UK£19.25 | PE40.4x | E11.0% | 2.2% | ||
MHCMyHealthChecked | UK£0.12 | -7.8% | -31.9% | UK£6.1m | n/a | PE32.3x | n/a | n/a | ||
AMSAdvanced Medical Solutions Group | UK£2.11 | -1.9% | -14.3% | UK£457.5m | UK£2.43 | PE23.3x | E6.8% | 1.0% | ||
EKFEKF Diagnostics Holdings | UK£0.27 | 0.4% | 1.9% | UK£123.4m | n/a | PS2.2x | E99.4% | 4.4% | ||
TRLSTrellus Health | UK£0.028 | -15.4% | -62.1% | UK£4.4m | n/a | PS258.6x | n/a | n/a | ||
FDBKFeedback | UK£1.13 | -8.2% | -34.6% | UK£15.0m | UK£2.40 | PS16.9x | S57.1% | n/a | ||
AGLANGLE | UK£0.15 | -6.3% | -34.1% | UK£39.1m | n/a | PS21.5x | E42.4% | n/a | ||
PHSCPHSC | UK£0.21 | 0% | 65.4% | UK£2.4m | n/a | PE9.2x | n/a | 8.1% | ||
CNSLCambridge Nutritional Sciences | UK£0.029 | 9.4% | -13.4% | UK£6.9m | n/a | PB0.7x | n/a | n/a | ||
SPECINSPECS Group | UK£0.55 | -5.2% | -44.7% | UK£55.4m | n/a | PB0.5x | E62.4% | 0% | ||
IUGIntelligent Ultrasound Group | UK£0.098 | 11.4% | 9.9% | UK£31.9m | n/a | PS3.1x | E108.1% | n/a | ||
ABDXAbingdon Health | UK£0.07 | -6.7% | 33.3% | UK£21.6m | n/a | PS5.3x | n/a | n/a | ||
SUNSurgical Innovations Group | UK£0.0055 | -15.4% | -71.8% | UK£5.1m | n/a | PB0.5x | S4.3% | n/a | ||
OBIOndine Biomedical | UK£0.092 | 0% | -50.0% | UK£21.0m | n/a | PS45.1x | E-7.5% | n/a | ||
POLXPolarean Imaging | UK£0.048 | -10.3% | -78.7% | UK£10.4m | n/a | PS38.9x | S55.2% | n/a | ||
RUARUA Life Sciences | UK£0.10 | 3.6% | -82.0% | UK£6.2m | n/a | PS3.3x | E73.5% | n/a | ||
IQAIIQ-AI | UK£0.018 | 0% | -41.9% | UK£4.0m | n/a | PS7.1x | n/a | n/a | ||
KOOKooth | UK£2.86 | -1.7% | 66.8% | UK£104.0m | UK£5.03 | PS4.6x | E69.4% | n/a | ||
TECHTechFinancials | UK£0.0026 | 0% | -20.0% | UK£222.8k | n/a | PB0.7x | n/a | n/a | ||
CVSGCVS Group | UK£10.92 | -25.7% | -41.7% | UK£783.1m | UK£20.04 | PE22.1x | E12.7% | 0.7% |